Oracle’s stock suffers worst eight-day stretch in over two decades. Here’s why.

Hammered by the general software selloff and AI debt concerns, shares of Oracle have shed 22% over eight trading sessions ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Reuters

Oracle Corp

WEC Energy boosts spending by $1 billion as Microsoft data centers expand in Wisconsin Wisconsin-based U.S. electric utility WEC Energy Group Inc said on Thursday that it will increase capital ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...